Masonic Cancer Center, University of Minnesota

What's Inside

Quick Links for:

Cancer Information Line
Ask about cancer, clinical trials, and how to make an appointment:
cancerinfo@umn.edu
612-624-2620

Toll-free in IA, MN, ND, SD, WI: 1-888-CANCER MN
(1-888-226-2376)

A Comprehensive Cancer Center Designated by the National Cancer Institute
Print this page. Mail this link to a friend.

Melissa A. Geller, M.D.

geller

Research Program: Women's Cancer
Assistant Professor, Department of Obstetrics, Gynecology and Women's Health

gelle005@umn.edu
612-626-3111, office

Dr. Geller's clinical profile
(University of Minnesota Physicians Web site)

Dr. Geller graduated cum laude with honors in Biology from Boston College. She received her M.D. degree from Chicago Medical School Finch University of Health Sciences and completed her residency in Obstetrics and Gynecology at the University of Minnesota. She conducted a fellowship in gynecologic oncology surgery at Memorial-Sloan Kettering Cancer Center followed by a fellowship in gynecologic oncology at the University of Minnesota. She joined the faculty in the Department of Obstetrics, Gynecology and Women's Health in 2005.

Research Interests

Dr. Geller's clinical interests are ovarian cancer and the treatment of uterine tumors. Her active research interests are as follows:

  1. MCP-1 (Macrophage Chemotactic Protein-1) levels in patients with newly diagnosed ovarian cancer receiving chemotherapy
  2. Women's Cancer Center Protocol # 38: A Phase II trial of induction carboplatin and docetaxel followed by radiotherapy then consolidation chemotherapy with carboplatin and docetaxel in Stage III, IV, and recurrent endometrial cancer
  3. Alterations in Serotonin (5-HT) signaling as a mechanism for chemotherapy induced constipation in Ovarian Cancer Patients
  4. Use of multimedia materials for educational materials for women with newly diagnosed ovarian cancer

Selected Publications

Ghosh K, Geller MA, Twiggs LB. Erosion of an intraperitoneal chemotherapy catheter resulting in an enterovaginal fistula. Gynecol Oncol. 2000;7:327-329.

Judson PL, Geller MA, Bliss RL, Boente MP, Downs LS Jr, Argenta PA, Carson LF. Preoperative detection of peripherally circulating cancer cells and its prognostic significance in ovarian cancer. Gynecol Oncol. 2003;91:389-394.

Geller MA, Argenta P, Bradley W, Dusenbery KE, Brooker D, Downs LS Jr, Judson PL, Carson LF, Boente MP. Treatment and recurrence patterns in endometrial stromal sarcomas and the relation to c-kit expression. Gynecol Oncol. 2004;95:632-636.

Ramakrishnan S, Subramanian IV, Yokoyama Y, Geller M. Angiogenesis in normal and neoplastic ovaries. Angiogenesis 2005;7:1-14.

Chura JC, Truskinovsky AM, Judson PL, Johnson L, Geller MA, Downs LS Jr. Positron emission tomography and leiomyomas: Clinicopathologic analysis of 3 cases of PET scan-positive leiomyomas and literature review. Gynecol Oncol. 2007;104:247-252.

Leath CA III, Huh WK, Hyde J, Cohn DE, Resnick KE, Taylor NP, Powell MA, Mutch DG, Bradley WH, Geller MA, Argenta PA, Gold MA. A Multi-institutional Review of Outcomes of Endometrial Stromal Sarcoma. Gynecol Oncol.  2007; 105:630-634.

Chura JC, Marushin R, Boyd A, Ghebre R, Geller MA, Argenta PA. Multimodal therapy improves survival in patients with CNS metastasis from uterine cancer:  A retrospective analysis and literature review.  Gynecol Oncol. 2007 [Epub ahead of print].